Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382119 · ClinicalTrials.gov registry record
Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography
A clinical trial of Liver Fibroses, sponsored by University of Michigan.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03382119: Completed study of Liver Fibroses, sponsored by University of Michigan.
NCT03382119 is a study of Liver Fibroses that has completed, run by University of Michigan. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03382119, a study of Liver Fibroses, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease. The study is measuring liver stiffness in pediatric patients aged 2-5 years. Patients either have had a Fontan cardiac surgery or have liver disease. Ultrasound scanning takes images of the liver and has much lower risks for patients. ARFI elastography and other tools can be used to measure liver stiffness.
Primary Outcome
Shear wave speed is a measure of stiffness of liver tissue expressed in units of m/s
Conditions Studied
Interventions
- DEVICE Ultrasound with ARFI (acoustic radiation force impulse)
- DEVICE Ultrasound with backscatter imaging
Study Locations (1)
Michigan
- C.S. Mott Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-04-11 |
| Est. Completion | 2019-07-19 |
What the finished NCT03382119 record still lists
NCT03382119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Liver Fibroses appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound with ARFI (acoustic radiation force impulse) is the first listed.
NCT03382119 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03382119 about?
NCT03382119 is a clinical study titled "Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography". The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease. The study is measuri...
What is the current status of trial NCT03382119?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-04-11. Estimated completion is 2019-07-19.
What conditions does trial NCT03382119 study?
This clinical trial studies the following conditions: Liver Fibroses.
What interventions are being tested in trial NCT03382119?
The interventions under investigation include: Ultrasound with ARFI (acoustic radiation force impulse) (DEVICE), Ultrasound with backscatter imaging (DEVICE).
Who is sponsoring clinical trial NCT03382119?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382119 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Fibroses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI